Articles

Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study

The Catholic University of Korea, Seoul, South Korea
Seoul National University, College of Medicine, Seoul, South Korea
Ruijin Hospital, Shanghai Second Medical University, Shanghai, China
Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
Taipei Veterans General Hospital, Taipei, Taiwan
Novartis Pharma AG, Basel, Switzerland
Novartis Pharmaceuticals, East Hanover, NJ, USA
Novartis Pharma AG, Basel, Switzerland
University College London, London, UK
Vol. 98 No. 7 (2013): July, 2013 https://doi.org/10.3324/haematol.2012.077669